OMNIAB, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.79 USD | -6.65% |
|
-9.55% | -38.57% |
| 05-29 | Omniab Insider Bought Shares Worth $1,059,840, According to a Recent SEC Filing | MT |
| 05-09 | Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M | MT |
Chart calendar OmniAb, Inc.
aa.gWvLgRonOAR8R_f1YhvwBAHpidD7thOwfBGn763Aa1o.5SSAzSoUSEIeKKbYKF-TSkOC1v2I1UPxFkjSg4CiIyzHP5Pee2laSQYKmA~339e5dce16daa116beceb9c0a39a3765
Upcoming events on OmniAb, Inc.
Past events on OmniAb, Inc.
| 17/06/2024 | Annual General Meeting |
| 05/06/2024 13:00 | Jefferies Global Healthcare Conference |
| 30/05/2024 14:00 | Leerink Partners Healthcare Crossroads Conference |
| 28/05/2024 | Craig Hallum Institutional Investor Conference |
| 22/05/2024 20:00 | Benchmark Healthcare House Virtual Conference |
| 20/05/2024 14:30 | H.C. Wainwright BioConnect Investor Conference |
| 15/05/2024 16:30 | RBC Capital Markets Global Healthcare Conference |
| 09/05/2024 21:30 | Q1 2024 Earnings Call |
| 09/05/2024 21:05 | Q1 2024 Earnings Release |
| 20/03/2024 20:30 | Q4 2023 Earnings Call |
| 20/03/2024 20:05 | Q4 2023 Earnings Release |
| 11/03/2024 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 16:10 | TD Cowen Health Care Conference |
| 15/11/2023 | Craig-Hallum Alpha Select Conference |
| 15/11/2023 13:00 | Stifel Healthcare Conference |
| 09/11/2023 16:00 | Q3 2023 Earnings Call |
| 09/11/2023 13:00 | Q3 2023 Earnings Release |
| 25/09/2023 | Cantor Global Healthcare Conference |
| 12/09/2023 14:00 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 21:30 | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 59,1 50,9 16.09% | 34,2 37,8 -9.72% | 29,3 |
|
EBITDA Million USD | Released Forecast Spread | -13,6 -1,22 -1014.59% | -55,9 -46,3 -20.57% | -58,0 |
|
EBIT Million USD | Released Forecast Spread | -26,6 -32,0 16.63% | -69,4 -64,7 -7.24% | -79,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,1 -49,2 47.01% | -64,4 -59,9 -7.41% | -75,9 |
|
Net income Million USD | Released Forecast Spread | -22,3 -37,5 40.44% | -50,6 -50,9 0.53% | -66,5 |
|
EPS USD | Released Forecast Spread | -0,26 -0,37 30.11% | -0,51 -0,51 -0.74% | -0,63 |
| Announcement Date | 30/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,91 | 35,3 24,7 42.89% | 16,9 18,8 -10.23% | 6,95 11,9 -41.69% | 5,48 10,3 -46.98% | 4,82 7,46 -35.4% | 3,80 5,87 -35.22% | 5,77 | 8,36 | 11,4 | 9,62 | 10,1 |
|
EBITDA Million USD | Released Forecast Spread | -5,08 -8,50 40.19% | -16,1 -13,7 -17.22% | -16,9 -16,4 -3.47% | -17,8 -12,7 -40.6% | -17,6 -15,8 -11.44% | -17,7 | -13,5 | -9,23 | -12,9 | -12,7 | ||
|
EBIT Million USD | Released Forecast Spread | 9,05 3,47 160.48% | -8,45 -5,43 -55.65% | -19,4 -12,4 -57.2% | -20,3 -15,5 -30.68% | -21,2 -18,1 -16.92% | -22,6 -19,5 -15.41% | -22,1 | -19,6 | -17,3 | -17,8 | -17,7 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,64 -6,21 255.19% | -7,13 5,30 -234.44% | -18,2 -12,1 -50.22% | -19,0 -14,7 -29.2% | -20,0 -17,1 -17.46% | -21,6 -18,5 -16.66% | -20,4 | -18,1 | -15,7 | -12,0 | -12,1 | |
|
Net income Million USD | Released Forecast Spread | -12,6 | 6,82 -1,10 721.7% | -6,10 5,67 -207.65% | -14,7 -10,9 -35% | -15,7 -14,2 -10.68% | -14,1 -15,7 10.33% | -19,0 -16,3 -16.67% | -18,1 | -16,0 | -13,4 | -12,7 | -12,6 |
|
EPS USD | Released Forecast Spread | 0,07 -0,02 450% | -0,06 0,06 -205.88% | -0,15 -0,11 -36.36% | -0,16 -0,14 -13.13% | -0,14 -0,15 7.44% | -0,19 -0,16 -17.83% | -0,17 | -0,15 | -0,13 | -0,14 | -0,14 | |
| Announcement Date | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 20/03/24 | 09/05/24 | - | - | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for OmniAb, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OABI Stock
- Calendar OmniAb, Inc.
